PTEN mutation, loss of heterozygosity, promoter methylation and expression in colorectal carcinoma: Two hits on the gene?

Hühns,Maja; Salem,Tareq; Schneider,Björn; Krohn,Mathias; Linnebacher,Michael; Prall,Friedrich

doi:10.3892/or.2014.3097

PTEN mutation, loss of heterozygosity, promoter methylation and expression in colorectal carcinoma: Two hits on the gene?

Authors:
- Maja Hühns
- Tareq Salem
- Björn Schneider
- Mathias Krohn
- Michael Linnebacher
- Friedrich Prall
View Affiliations

Affiliations: Institute of Pathology, Rostock University, D-18055 Rostock, Germany, Department of Surgery, Rostock University, D-18055 Rostock, Germany
Published online on: March 19, 2014 https://doi.org/10.3892/or.2014.3097
Pages: 2236-2244

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The phosphatase and tensin homologue (PTEN) gene is considered to be a tumour-suppressor gene in various types of cancer, colorectal carcinoma among them. According to the ‘two-hit’ tumour-suppressor gene concept, inactivation occurs by any combination of the following three pathogenetic processes: mutation, loss of one allele [i.e. loss of heterozygosity (LOH)] or promoter methylation. To determine the frequencies of PTEN tumour-suppressor gene features in colorectal carcinoma, we used DNA from colorectal carcinoma xenografts/primary tumour cell lines (N=22) or neoplastic glands isolated by laser-capture microdissection (N=20). Sequencing exons 1-9 of the gene revealed a total of 8 somatic mutations in 5 tumours (3 with high-degree microsatellite instability). In 1 tumour, a truncating mutation of one allele was combined with two missense mutations of the other allele. Polymorphic microsatellite marker analyses (D10S5412, D10S579 and D10S1765) showed complete loss of one allele (i.e. LOH sensu stricto) in 3 tumours, but combined LOH and mutation was found only once. Promoter methylation, tested by MethyLight technology, was found in only 1 of the tumours, not combined with mutation or LOH. In contrast, by immunohistochemistry (mAb 6H2.1), reduction or even loss of PTEN expression was found in 18 tumours. Taken together, PTEN downregulation is a fairly frequent event in colorectal carcinoma, but this apparently is not usually caused by two hits on the gene.

View Figures

View References

1	Wood LD, Parsons DW, Jones S, et al: The genomic landscapes of human breast and colorectal cancers. Science. 318:1108–1113. 2007. View Article : Google Scholar : PubMed/NCBI
2	Planchon SM, Waite KA and Eng C: The nuclear affairs of PTEN. J Cell Sci. 121:249–253. 2008. View Article : Google Scholar : PubMed/NCBI
3	Steck PA, Pershouse MA, Jasser SA, et al: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 15:356–362. 1997.PubMed/NCBI
4	Shin KH, Park YJ and Park JG: PTEN mutations in colorectal cancers displaying microsatellite instability. Cancer Lett. 174:189–194. 2001. View Article : Google Scholar
5	Devilee P, Cleton-Jansen AM and Cornelisse CJ: Ever since Knudson. Trends Genet. 17:569–573. 2001. View Article : Google Scholar : PubMed/NCBI
6	Vogelstein B, Papadopoulos N, Velculescu V, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes. Science. 339:1546–1558. 2013. View Article : Google Scholar : PubMed/NCBI
7	Goel A, Arnold CN, Niedzwiecki D, et al: Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res. 64:3214–3221. 2004. View Article : Google Scholar : PubMed/NCBI
8	Oberländer M, Linnebacher M, König A, et al: The ‘North German Tumor Bank of Colorectal Cancer’: status report after the first 2 years of support by the German Cancer Aid Foundation. Langenbecks Arch Surg. 398:251–258. 2013.
9	Linnebacher M, Maletzki C, Ostwald C, Klier U, Krohn M, Klar E and Prall F: Cryopreservation of human colorectal carcinomas prior to xenografting. BMC Cancer. 10:3622010. View Article : Google Scholar : PubMed/NCBI
10	Ostwald C, Linnebacher M, Weirich V and Prall F: Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification. Int J Oncol. 35:321–327. 2009.
11	Ogino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner GJ, Weisenberger DJ, Campan M, et al: CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut. 55:1000–1006. 2006. View Article : Google Scholar : PubMed/NCBI
12	Nassif NT, Lobo GP, Wu X, Henderson CJ, Morrison CD, Eng C, Jalaludin B and Segelov E: PTEN mutations are common in sporadic microsatellite stable colorectal cancer. Oncogene. 23:617–628. 2004. View Article : Google Scholar
13	Zhou XP, Loukola A, Salovaara R, Nystrom-Lahti M, Peltomäki P, de la Chapelle A, Aaltonen LA and Eng C: PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers. Am J Pathol. 161:439–447. 2002. View Article : Google Scholar
14	Perren A, Weng LP, Boag AH, et al: Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol. 155:1253–1260. 1999. View Article : Google Scholar : PubMed/NCBI
15	Garcia JM, Rodriguez R, Silva J, et al: Intratumoral heterogeneity in microsatellite alterations in BRCA1 and PTEN regions in sporadic colorectal cancer. Ann Surg Oncol. 10:876–881. 2003. View Article : Google Scholar : PubMed/NCBI
16	Linnebacher M, Ostwald C, Koczan D, et al: Single nucleotide polymorphism array analysis of microsatellite-stable, diploid/near-diploid colorectal carcinomas without the CpG island methylator phenotype. Oncol Lett. 5:173–178. 2013.
17	Perrone F, Lampis A, Orsenigo M, et al: PIK3CA/PTEN deregulation contributes to impaired responses to cetuximab in metatatic colorectal cancer patients. Ann Oncol. 20:84–90. 2009. View Article : Google Scholar
18	Razis E, Briasoulis E, Vrettou E, et al: Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study. BMC Cancer. 8:2342008. View Article : Google Scholar : PubMed/NCBI